Detalhe da pesquisa
1.
Phase II Clinical Trial of Pembrolizumab and Chemotherapy Reveals Distinct Transcriptomic Profiles by Radiologic Response in Metastatic Triple-Negative Breast Cancer.
Clin Cancer Res
; 30(1): 82-93, 2024 01 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37882661
2.
Functional landscapes of POLE and POLD1 mutations in checkpoint blockade-dependent antitumor immunity.
Nat Genet
; 54(7): 996-1012, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35817971